FDA Inspection 1264352 — Gregory D. Parkhurst, MD
The FDA completed an inspection of Gregory D. Parkhurst, MD on Mar 13, 2025 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 13, 2025
- Fiscal Year
- 2025
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- San Antonio, TX (United States)
Additional details
Clinical Investigator (CI)